Skip to main content

Table 3 The comparison of drugs treatment used between 50 severe acute respiratory infection (sARI) cases and 79 controls infected with pH1N1 influenza

From: Severe acute respiratory infection risk following glucocorticosteroid treatment in uncomplicated influenza-like illness resulting from pH1N1 influenza infection: a case control study

DrugsNumber exposedPercent exposedMatched odds ratioa (95%CI)Conditional logistic regression
Case (N = 50)Control (N = 79)CaseControl
Glucocorticosteroidsb30560.06.316.7(5.8–47.7)8.2(2.3–29.0)
Pyrazolonesc15630.07.64.7(1.6–13.7)3.3(0.8–14.6)
Neuraminidase inhibitor37774.08.924.5(8.7–68.4)14.8(4.9–45.2)
Amantidine366.07.60.9(0.2–3.8) 
Ribavirin273654.045.61.3(0.6–2.8) 
Other antivirals153230.040.50.6(0.2–1.3) 
Antibiotics476794.084.83.4(0.8–13.4)1.0(0.2–5.5)
Acetaminophen151730.021.51.7(0.7–3.8) 
Ibuprofen151630.020.32.1(0.9–5.0)2.1(0.7–7.1)
Nimesulide91518.019.01.0(0.4–2.7) 
Traditional Chinese medicine335966.074.70.5(0.2–1.2) 
  1. aOdds Ratio is matched by underlying disease, bdexamethasone or methyl prednisolone, caminopyrine or dipyrone